公司资料
IQVIA 股价、新闻与催化剂
- 股票代码:
- IQV
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
260.72 USD (-3.02%)
收盘价
最后更新: 2026年10月1日
30.1B USD
市值
股价为何变动
截至 2026年10月1日，IQV 下跌 3.02%，收于 $260.72。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Life Sciences Data and Services Company
IQVIA provides clinical research services, commercial insights, and healthcare intelligence to pharmaceutical, biotechnology, medical-device, payer, and public-sector customers. Its model combines global execution capabilities with large healthcare datasets, analytics, and technology.
Research and Development Solutions
Research and Development Solutions supports clinical trials from study design and site selection through patient recruitment, monitoring, data management, and regulatory submission. The business operates globally and generates substantial contracted backlog from multiyear development programs.
Commercial Solutions
Commercial Solutions provides market data, real-world evidence, consulting, technology, patient support, and commercial engagement services. Customers use these offerings to assess markets, plan launches, optimize field operations, and measure product performance.
Connected Intelligence Platform
IQVIA Connected Intelligence links proprietary data, healthcare-grade AI, advanced analytics, and domain expertise. The platform is designed to convert fragmented clinical and commercial information into decisions across drug development and commercialization.
Global Scale and Therapeutic Expertise
IQVIA operates in more than 100 countries with expertise spanning clinical operations, data science, technology, and healthcare markets. This scale allows the company to support multinational trials and commercial programs while adapting to local regulatory and privacy requirements.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。